Regional differences in the ability of caffeine to affect haloperidol-induced striatal c-fos mRNA expression in the rat

Neuropharmacology

Volumn 37, Issue 3, 1998, Pages 331-337

  Svenningsson, Per ^a   Nergårdh, Ricard ^a   Fredholm, Bertil B ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Adenosine receptors; Caudate putamen; Cerebral cortex; Dopamine receptors; Methylxanthines; Neuroleptics

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR ANTAGONIST; ADENOSINE RECEPTOR; CAFFEINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; HALOPERIDOL; MESSENGER RNA; METHYLXANTHINE; NEUROLEPTIC AGENT; PROTEIN C FOS; RACLOPRIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CINGULATE GYRUS; CONTROLLED STUDY; CORPUS STRIATUM; GENE EXPRESSION REGULATION; NEUROPHARMACOLOGY; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SOMATOSENSORY CORTEX; SUBSTANTIA NIGRA;

ANIMALS; CAFFEINE; GENES, FOS; HALOPERIDOL; IN SITU HYBRIDIZATION; NEOSTRIATUM; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; RNA, MESSENGER;

EID: 0032029264     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(98)00045-8     Document Type: Article

References (28)

1. Boegman R.J., Vincent S.R. Involvement of adenosine and glutamate receptors in the induction of c-fos in the striatum by haloperidol. Synapse. 22:1996;70-77.
2. 2 subtypes of dopamine receptors in rat brain. J. Neurosci. 6:1986;3177-3188.
3. Curran T., Gordon M.B., Rubino K.L., Sambucetti L.C. Isolation and characterization of the c-fos (rat) cDNA and analysis of post-transcriptional modification in vitro. Oncogene. 2:1987;79-84.
4. Daly J.W. Mechanism of action of caffeine. Garrattini S. Caffeine, Coffee and Health. 1993;97-150 Raven Press, New York.
5. 1 receptors and 5′-nucleotidase in the brain of some commonly used experimental animals. Neuroscience. 22:1987;813-826.
6. Ferré S., Fuxe K., von Euler G., Johansson B., Fredholm B.B. Adenosine-dopamine interactions in the brain. Neuroscience. 51:1992;501-512.
7. 2 dopamine receptors in rat striatum. Mol. Brain Res. 14:1992;186-195.
8. Fredholm B.B. Adenosine, adenosine receptors and the actions of caffeine. Pharmacol. Toxicol. 75:1995;93-101.
9. Gerfen C. The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci. 15:1992;133-139.
10. Hamera E., Schneider J.K., Deviney S. Alcohol, cannabis, nicotine and caffeine use and symptom distress in schizophrenia. J. Nerv. Ment. Dis. 183:1995;559-565.
11. Johansson B., Herrera-Marschitz M., Svenningsson P., Fredholm B.B. Caffeine-induced expression of the proto-oncogene c-fos in rat striatum is increased after dopamine denervation. Acta Physiol. Scand. 149:1993;527-529.
12. Lucas P.B., Pickar D., Kelsoe J., Rapaport M., Pato C., Hommer D. Effects of the acute administration of caffeine in patients with schizophrenia. Biol. Psychiatry. 28:1990;35-40.
13. McGeorge A.J., Faull R.L.M. The organization of the projection from the cerebral cortex to the striatum of the rat. Neuroscience. 29:1989;503-537.
14. 1 adenosine receptor from rat brain. Mol. Pharmacol. 40:1991;1-7.
15. Maura G, Giardi A, Raiteri M Release-regulating D-2 dopamine receptors are located on striatal glutamatergic nerve terminals. J. Pharmacol. Exp. Ther. 247:1988;680-684.
16. Mikkelsen E.J. Caffeine and schizophrenia. J. Clin. Psychiatry. 39:1978;732-736.
17. Nakajima T., Daval J.L., Morgan P.F., Post R.M., Marangos P.J. Adenosinergic modulation of caffeine-induced c-fos mRNA expresssion in mouse brain. Brain Res. 501:1989;307-314.
18. Okada M., Kiryu K., Kawata Y., Mizuno K., Wada K., Tasaki H., Kaneko S. Determination of the effects of caffeine and carbamazepine on striatal dopamine release by in vivo microdialysis. Eur. J. Pharmacol. 321:1997;181-188.
19. 3H]CGS 21 680 as a ligand, Naunyn-Schmiedeberg's. Arch. Pharmacol. 342:1990;85-89.
20. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 2nd edn:1986;1986 Academic Press, North Ryde, Australia.
21. 2 dopamine receptors differentially regulate c-fos expression in striato-nigral and striato-pallidal neurons. Neuroscience. 49:1992;285-296.
22. 1 dopamine receptor. Brain Res. 519:1990;333-337.
23. 2 receptors regulate the gene expression of striatopallidal and striatonigral neurons. J. Neurosci. 13:1993;1080-1087.
24. Sheng M., Greenberg M.E. The regulation and function of c-fos and other immediate early genes in the nervous system. Neuron. 4:1990;477-485.
25. Svenningsson P., Nomikos G.G., Fredholm B.B. Biphasic changes in locomotor behaviour and in expression of mRNA for NGFI-A and NGFI-B in rat striatum following acute caffeine administration. J. Neurosci. 15:1995;7612-7624.
26. Svenningsson P., Johansson B., Fredholm B.B. Caffeine-induced expression of c-fos mRNA and NGFI-A mRNA in caudate putamen and in nucleus accumbens are differentially affected by the N-methyl-D-aspartate receptor antagonist MK-801. Mol. Brain Res. 35:1996;183-189.
27. 2A receptor messenger RNA in the rat central nervous system with special reference to dopamine innervated areas. Neuroscience. 80:1997a;1171-1185.
28. 2A receptors underlies the behavioural activating effect of caffeine and is associated with reduced expresssion of messenger RNA for NGFI-A and NGFI-B in caudate-putamen and nucleus accumbens. Neuroscience. 79:1997b;753-764.